Successful retreatment with 3-week rituximab-bendamustine with high-dose dexamethasone in patients with relapsed/refractory mantle cell lymphoma.

Lamm, Wolfgang; Kiesewetter, Barbara; Puhr, Hannah; Dolak, Werner; Mayerhöfer, Marius E; Raderer, Markus

Lamm, Wolfgang; Kiesewetter, Barbara; Puhr, Hannah; Dolak, Werner; Mayerhöfer, Marius E; Raderer, Markus.

Affiliation

Lamm W; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria. wolfgang.lamm@meduniwien.ac.at.
Kiesewetter B; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Puhr H; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Dolak W; Department of Medicine III, Clinical Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
Mayerhöfer ME; Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Raderer M; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.

Ann Hematol ; 98(6): 1519-1520, 2019 Jun.

Article in En | MEDLINE | ID: mdl-30547188

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Mantle-Cell Type of study: Etiology_studies / Observational_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2019 Document type: Article Affiliation country: Austria Country of publication: Alemania

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google